About Transcatheter Technologies
Transcatheter Technologies is a Healthcare company based in Regensburg (Germany) founded in 2009, and was acquired by Venus MedTech in April 2016. It operates as an implantable devices for heart valve repair and replacement. Transcatheter Technologies has raised $6.7 million across 4 funding rounds from investors including Venus MedTech, KfW and High-Tech Gründerfonds. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis and 5 more; 10 of its 10 listed competitors have raised funding.
Company details
Transcatheter Technologies is a medical device company specializing in catheter-based heart valve implantation and aortic therapy. Key products in development are the transcatheter aortic valve implantation system TRINITY, the transcatheter mitral valve implant TRESILLO and the endovascular aortic repair stent TUMBAO.
- Headquarters Regensburg, Germany
- SectorsHealthcare
- Website transcatheter-technologies.com
- Social LinkedIn
- Acquired by Venus MedTech (Apr 2016)
- Total Equity Funding$6.7M (USD)
in 4 rounds
- InvestorsVenus MedTech
& 4 more
- Acquired byVenus MedTech
(Apr 2016)
Funding Insights of Transcatheter Technologies
Transcatheter Technologies has successfully raised a total of $6.7M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.7M
- Total Rounds 4
- First Round $835,908
(Jul 2009)
- Investors Count 4
All 4 funding rounds of Transcatheter Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2014 | – | Series B | – | – | – |
| Mar 2013 | $3.34M | Series B | – | – | – |
| May 2011 | $2.52M | Series A | – | – | |
| Jul 2009 | $835,908 | Seed | – | – |
5 investors in total: 5 institutional.
Investors in Transcatheter Technologies
Transcatheter Technologies has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Venus MedTech, KfW and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in high-tech startups by HTGF. | – | htgf.de | Bonn, Germany | |
- | – | tubaflex.com | - | |
High-tech industries are targeted for investments by Bayern Kapital. | – | bayernkapital.de | Landshut, Germany | |
Consumer and SME loans are provided across Germany. | 1948 | kfw.de | Frankfurt Am Main, Germany | |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures. | 2009 | venusmedtech.com | Hangzhou, China |
Investor details for Transcatheter Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Transcatheter Technologies
4 dated milestones of Transcatheter Technologies across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Transcatheter Technologies is founded.
- Funding First funding round of $836K.
- Funding Latest funding round, Series B,.
- Exit Acquired by Venus MedTech.
Competitors of Transcatheter Technologies
Transcatheter Technologies has 10 listed competitors in our database, 10 of them funded. They include Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| shockwavemedical.com | 2009 | Santa Clara, United States | $147.5M | 1,394 | Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed. | |
| cardiacdimensions.com | 2001 | Kirkland, United States | $260.8M | 31 | Invasive cardiac implants for heart failure treatment are developed. | |
| venusmedtech.com | 2009 | Hangzhou, China | $37M | – | Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures. | |
| pi-cardia.net | 2009 | Rehovot, Israel | $40M | – | Non-implant devices for cardiac valve repair are developed and manufactured. | |
| symetis.com | 2001 | Ecublens, Switzerland | $56.66M | – | Minimally invasive heart valve replacement devices are developed and marketed. | |
| peijiamedical.com | 2012 | Suzhou, China | $110.08M | – | Medical devices for cardiac and cerebrovascular treatments are developed. | |
| jenavalve.com | 2006 | Irvine, United States | $363.7M | 198 | Pericardial transcatheter aortic valve replacement systems are provided. | |
| neochord.com | 2007 | Eden Prairie, United States | $108.67M | 7 | Minimally invasive mitral valve repair devices are developed and provided. | |
| capstanmedical.com | 2020 | Santa Cruz, United States | $141.4M | – | Medical devices for structural heart disease treatment are developed. | |
| cardioflowmedtech.com | 2015 | Pudong, China | $132.02M | – | Smart medical devices for heart valve diseases are developed. |
Detailed competitors of Transcatheter Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Transcatheter Technologies (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Transcatheter Technologies
Transcatheter Technologies was founded in 2009.
Transcatheter Technologies is headquartered in Regensburg, Germany. It is registered at Regensburg, Bavaria, Germany.
Transcatheter Technologies is a funded company, having raised a total of $6.7M across 4 funding rounds to date. The company's 1st funding round was a Seed of $835.91K, raised on Jul 2009.
Transcatheter Technologies is a medical device company specializing in catheter-based heart valve implantation and aortic therapy. Key products in development are the transcatheter aortic valve implantation system TRINITY, the transcatheter mitral valve implant TRESILLO and the endovascular aortic repair stent TUMBAO.
Transcatheter Technologies's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
Transcatheter Technologies has 5 investors. Key investors include Venus MedTech, KfW, High-Tech Gründerfonds, Tubaflex, and Bayern Kapital.
Yes. Transcatheter Technologies was acquired by Venus MedTech in April 2016.